Sex Differences in the Treatment of People with Parkinson’s Disease with a Device-Aided Therapy: A Prospective Real-World Study
Medical Sciences · 27.04.2026 · 14 (2) · 217
DOI: 10.3390/medsci14020217 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Medical Sciences, online erschienen am 27.04.2026. Verfasst von Diego Santos García und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006 A …. Hauptthemen laut MEDLINE: Deep Brain Stimulation, Parkinson Disease. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundación Degen, Sociedad Española de Neurología, Grupo de Estudio de Trastornos del Movimiento.
Abstract (Originalsprache)
Background and Objective: Sex differences in the treatment of people with Parkinson’s disease (PwP) with a device-aided therapy (DAT) have been poorly investigated. Our aim was to analyze sex differences in the management and response to a DAT in PwP in daily clinical practice (DCP). Patients and Methods: Data collected in the DATs-PD GETM Spanish Registry until 30 October 2025 were used. This is a descriptive, observational, prospective, and multicenter clinical registry with progressive inclusion of PwP treated with a DAT in DCP conditions in more than 40 centers from Spain. Sex differences in the DAT received and changes in quality of life (QoL), motor symptoms (MS), non-motor symptoms (NMS), and autonomy for activities of daily living (AADL) after 6 months of treatment were analyzed.
Results
A total of 618 PD patients (66.9 ± 9.5 years old; 57.6% men) were treated with a DAT. A significant difference was observed in the DAT type according to sex (p = 0.006), with 73.1% of PwP who were treated with deep brain stimulation being men. At the time of DAT indication, women were older, received a higher levodopa equivalent daily dose, and had a worse health-related QoL and AADL. OFF time decreased, whereas MS and NMS burden and health-related QoL improved at 6 months follow-up in both groups (men and women). AADL improved only in men during the OFF state.
Conclusion
Sex differences were detected in the use of DATs in PwP. Improvement in OFF time, MS, NMS, and QoL was detected in both groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, Hospital Universitario de A Coruña (HUAC), Complejo Hospitalario Universitario de A Coruña (CHUAC), C/As Xubias 84, 15006 A Coruña, Spain.
- Grupo de Investigación en Enfermedad de Parkinson y Otros Trastornos del Movimiento, INIBIC (Instituto de Investigación Biomédica de A Coruña), 15006 A Coruña, Spain.
- Hospital San Rafael, 15006 A Coruña, Spain.
- Fundación Degen, 15006 A Coruña, Spain.
- Hospital Universitario Central de Asturias (HUCA), 33011 Oviedo, Spain.
- Unidad de Trastornos del Movimiento, Servicio de Neurología, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, 41013 Seville, Spain.
ORCID-Profile: Diego Santos García, Ángela Solleiro Vidal, Marta Blázquez Estrada, Nuria López Ariztegui, Déborah Alonso Modino, Rocío García-Ramos, Iria Cabo, Pilar Sánchez Alonso, Jorge Hernández-Vara, Gustavo Fernández-Pajarín, Francisco Escamilla Sevilla, Jesús Ramírez Sánchez-Ajofrin, Guillermo González Ortega
Förderung
- Fundación Degen
- Sociedad Española de Neurología
- Grupo de Estudio de Trastornos del Movimiento
Zitieren
APA
Santos García, D., Solleiro Vidal, Á., Blázquez Estrada, M., Mir, P., López Ariztegui, N., Alonso Modino, D., Legarda, I., Peral, A., García-Ramos, R., Cabo, I., Sánchez Alonso, P., Hernández-Vara, J., Ruíz Martínez, J., Álvarez Sauco, M., Fernández-Pajarín, G., Vela, L., Escamilla Sevilla, F., Ramírez Sánchez-Ajofrin, J., Cerdán Santacruz, D. M., …, & DATs-Pd Getm Spanish Registry Group (2026). Sex Differences in the Treatment of People with Parkinson’s Disease with a Device-Aided Therapy: A Prospective Real-World Study. Medical Sciences, 14(2), 217. https://doi.org/10.3390/medsci14020217
Vancouver
Santos García D, Solleiro Vidal Á, Blázquez Estrada M, Mir P, López Ariztegui N, Alonso Modino D, et al. Sex Differences in the Treatment of People with Parkinson’s Disease with a Device-Aided Therapy: A Prospective Real-World Study. Medical Sciences. 2026;14(2):217. doi:10.3390/medsci14020217
BibTeX
@article{SantosGarca2026,
author = {Santos García, Diego and Solleiro Vidal, Ángela and Blázquez Estrada, Marta and Mir, Pablo and López Ariztegui, Nuria and Alonso Modino, Déborah and Legarda, Inés and Peral, Alejandro and García-Ramos, Rocío and Cabo, Iria and Sánchez Alonso, Pilar and Hernández-Vara, Jorge and Ruíz Martínez, Javier and Álvarez Sauco, María and Fernández-Pajarín, Gustavo and Vela, Lydia and Escamilla Sevilla, Francisco and Ramírez Sánchez-Ajofrin, Jesús and Cerdán Santacruz, Débora M and González Ortega, Guillermo and DATs-Pd Getm Spanish Registry Group},
title = {Sex Differences in the Treatment of People with Parkinson’s Disease with a Device-Aided Therapy: A Prospective Real-World Study},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {217},
doi = {10.3390/medsci14020217}
}
EUVIMED